EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications

Timur Saliev iD, Prim B Singh iD

Cells · 2024

DOI: 10.3390/cells13242052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Timur Saliev und 1 weiteren Autor:innen. Beteiligte Einrichtung: S.D. Asfendiyarov Kazakh National Medical University, Tole Bi Street 94, Almaty 050000, Kazakhstan. Hauptthemen laut MEDLINE: Rejuvenation. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Republic of Kazakhstan, Ministry of Science and Higher Education of the Republic of Kazakhstan “Prolonging healthy longevity: using new technologies and machine learning to control re….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular rejuvenation therapies represent a transformative frontier in addressing age-related decline and extending human health span. By targeting fundamental hallmarks of aging—such as genomic instability, epigenetic alterations, mitochondrial dysfunction, and cellular senescence—these therapies aim to restore youthful functionality to cells and tissues, offering new hope for treating degenerative diseases. Recent advancements have showcased a range of strategies, including epigenetic reprogramming, senolytic interventions, mitochondrial restoration, stem cell-based approaches, and gene-editing technologies like CRISPR. Each modality has demonstrated substantial potential in preclinical models and is now being cautiously explored in early-stage clinical trials. However, translating these therapies from the laboratory to clinical practice presents unique challenges: safety concerns, delivery precision, complex regulatory requirements, ethical considerations, and high costs impede widespread adoption. This review examines the current landscape of cellular rejuvenation, highlighting key advancements, potential risks, and the strategies needed to overcome these hurdles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RejuvenationHumansAnimalsCellular SenescenceCell- and Tissue-Based TherapyTranslational Research, BiomedicalGene EditingMitochondriaAgingEpigenesis, Genetic

Stichwörter der Autor:innen

CRISPRinduced pluripotent stem cellsmesenchymal stem cellsrejuvenationsenolytics

Autor:innen und Institutionen

  • S.D. Asfendiyarov Kazakh National Medical University, Tole Bi Street 94, Almaty 050000, Kazakhstan.
  • School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.

ORCID-Profile: Timur Saliev, Prim B Singh

Förderung

  • Ministry of Science and Higher Education of the Republic of Kazakhstan
  • Ministry of Science and Higher Education of the Republic of Kazakhstan “Prolonging healthy longevity: using new technologies and machine learning to control re…

Zitieren

APA

Saliev, T., & Singh, P. B. (2024). From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications. Cells. https://doi.org/10.3390/cells13242052

Vancouver

Saliev T, Singh PB. From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications. Cells. 2024. doi:10.3390/cells13242052

BibTeX
@article{Saliev2024,
  author = {Saliev, Timur and Singh, Prim B},
  title = {From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13242052}
}
Kostenlos starten →